Catalyst Wire Dossier Catalyst Wire Dossier

TQ-A3334 Tablet

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQ-A3334 Tablet, covering 2024-10-30 to 2024-10-30. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects [Phase 1]

See pricing